Uniphar Group PLC

Uniphar Group PLC

UPR · IR · Healthcare / Medical Distribution

3.98EUR+0.02 (+0.51%)

Price History

Full chart

Market Stats

Previous Close3.96
Open4.01
Day Range3.94 – 4.02
52-Week Range3.38 – 4.98
Volume655.66K
Market Cap1.06B
P/E (TTM)20.38
Forward P/E14.39
EPS0.2
Dividend Yield0.50%
Beta1.13
50-Day Avg4.15
200-Day Avg4.16

About

Uniphar plc, together with its subsidiaries, operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, the Netherlands, and internationally. It operates through three divisions: Uniphar Medtech, Uniphar Pharma, and Uniphar Supply Chain & Retail. The company provides sales, marketing, servicing, quality, compliance, regulatory support, and distribution services to medical device manufacturers; high-value services across the life cycle of a pharmaceutical product; and healthcare professionals with access to medicines that cannot source through traditional channels. It is also involved in the pre-wholesale and wholesale distribution of pharmaceutical, healthcare, and animal health products to pharmacies, hospitals and veterinary surgeons; operates a network of pharmacies under the Life, Allcare, Hickey's, and McCauley brands. In addition, the company provides pharmacy support, pharmaceutical supply chain and services, medical device distribution, specialist nursing and infusion, outsourcing and resourcing, healthcare technology, medical affairs, online pharmacy and product fostering, pharmaceutical wholesale distributor, retail pharmacy software and technology, and telecommunications support services, as well as specialist provider of pharmaceuticals. Uniphar plc was founded in 1967 and is headquartered in Dublin, Ireland.

Company Details

  • SectorHealthcare
  • IndustryMedical Distribution
  • CEOMr. Gerard Rabbette B.Comm FCA
  • Employees3.50K
  • Headquarters4045 Kingswood Road, Dublin, Ireland, D24 V06K, Ireland
  • Websitehttps://www.uniphar.ie

Leadership

  • Mr. Gerard Rabbette B.Comm FCACEO & Executive Director
  • Mr. Timothy Dolphin B.Comm FCACFO & Executive Director
  • Mr. Allan Smylie C.F.A.Head of Strategy and Investor Relations
  • Ms. Aisling McCarthyGeneral Counsel & Company Secretary
  • Mr. Seamus EganHead of Corporate Development
  • Mr. Brian O'ShaughnessyCCO and Commercial Lead of C&C Pharma & Product Access
  • Mr. Dermot RyanManaging Director
  • Ms. Kay BonavitaChief Commercial Officer for Uniphar Logistics
  • Rick HughesManaging Director of Uniphar Logistics

Financials

Income Statement

Line item2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.30B1.27B1.55B1.67B1.82B1.94B2.07B2.55B2.77B3.07B
Cost of Revenue1.21B1.19B1.39B1.48B1.61B1.67B1.76B2.16B2.34B2.62B
Gross Profit86.84M82.01M159.60M180.60M217.25M274.50M306.74M389.98M427.60M457.69M
Operating Income17.12M10.92M36.70M40.19M46.72M59.55M53.16M77.74M85.12M91.43M
EBITDA16.01M7.27M34.54M51.38M59.41M89.61M92.44M112.90M136.88M119.84M
Net Income5.74M-1.03M17.30M21.03M27.83M48.08M45.59M44.81M64.20M51.09M
Interest Expense3.01M2.81M6.30M6.51M5.87M6.93M9.29M24.59M25.92M21.19M

Balance Sheet

Line item2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets287.62M289.53M654.90M760.62M840.46M944.99M1.11B1.29B1.42B1.73B
Total Liabilities297.81M300.25M506.00M579.70M637.92M693.43M821.01M955.94M1.01B1.33B
Total Equity-10.20M-10.45M149.10M181.21M202.46M251.44M289.54M332.80M401.75M405.00M
Cash14.96M1.19M106.70M114.04M60.41M78.03M103.70M85.65M102.99M183.70M
Total Debt64.37M54.55M165.80M182.54M218.46M245.40M----
Net Debt49.41M53.37M59.10M68.50M158.05M167.38M91.22M150.12M147.97M171.37M

Cash Flow

Line item2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow23.70M-1.68M-8.74M107.00M65.98M52.18M82.83M52.51M124.27M108.43M
Investing Cash Flow8.23M-4.44M-82.00M-45.64M-110.33M-49.66M-106.33M---
Financing Cash Flow-28.60M-7.65M100.09M42.15M-8.71M13.26M50.41M---
Capital Expenditure9.87M4.91M4.89M6.45M15.74M14.43M13.96M31.95M102.09M62.82M
Free Cash Flow13.83M-6.59M-13.63M100.55M50.24M37.75M62.91M20.56M22.18M45.61M
Dividends Paid3.00K1.99M1.99M1.99M1.99M5.73M4.67M4.83M5.08M5.08M

Key Statistics & Ratios

Market Cap1.06B
Enterprise Value1.48B
Trailing P/E20.38
Forward P/E14.39
Price / Sales0.33
Price / Book2.45
EPS0.2
Book Value1.64
Revenue (TTM)3.18B
Gross Profit (TTM)474.53M
EBITDA109.03M
Profit Margin1.69%
Operating Margin2.56%
Return on Equity13.42%
Return on Assets3.64%
Shares Outstanding259.57M
Shares Float239.44M
Beta1.13
Dividend Yield0.50%
Dividend Rate0.02
Payout Ratio9.81%

Dividends

20231×
0.01Apr 20, 2023
20222×
0.01Sep 8, 20220.01Apr 21, 2022
20212×
0.01Sep 16, 20210.02Apr 22, 2021
20201×
0.01Apr 30, 2020